Indication

Gout

Gout is a common, chronic metabolic disorder and form of inflammatory arthritis characterized by the precipitation and deposition of monosodium urate monohydrate crystals in synovial joints and periarticular soft tissues. Read more about Gout

105 drugs 63 manufacturers

Advertisement

Drugs that treat it

Common Gout therapies.

Showing 1–9 of 105 drugs

NAPROXEN SODIUM

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·GOUT·+8
CVS

NAPROXEN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·GOUT·+8
Amneal Pharmaceuticals

MECLOFENAMATE SODIUM

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·GOUT·+8
Mylan Pharmaceuticals

INDOMETHACIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·GOUT·+9
GLENMARK PHARMA
Filter & compare in the drug finder →Opens the drug finder with Gout preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Gout.

Gout is a common, chronic metabolic disorder and form of inflammatory arthritis characterized by the precipitation and deposition of monosodium urate monohydrate crystals in synovial joints and periarticular soft tissues.

It is driven by persistent hyperuricemia resulting from urate overproduction, impaired renal or gastrointestinal excretion, or both.

Clinically, gout most often affects middle-aged and older adults, particularly men and postmenopausal women, typically presenting as acute, exquisitely painful, and self-limited monoarticular flares that predominantly involve the first metatarsophalangeal joint or other lower-extremity joints.

Left unmanaged, repeated inflammatory episodes can progress to chronic gouty arthropathy, joint destruction, nephrolithiasis, and the subcutaneous accumulation of nodular crystal aggregates known as tophi.

Personalize your experience

Follow Gout and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it